Get the Stockscreener App
77.05
0.71%
0.54
Pre-market:
77.25
0.20
+0.26%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Colgate Palmolive Co stock is traded at $77.05, with a volume of 17.70M.
It is up +0.71% in the last 24 hours and down -3.62% over the past month.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
See More
Previous Close:
$76.51
Open:
$75.55
24h Volume:
17.70M
Relative Volume:
3.06
Market Cap:
$62.27B
Revenue:
$20.00B
Net Income/Loss:
$3.05B
P/E Ratio:
21.66
EPS:
3.5578
Net Cash Flow:
$3.37B
1W Performance:
-1.22%
1M Performance:
-3.62%
6M Performance:
-16.42%
1Y Performance:
-17.78%
1-Day Range:
$74.62
$77.16
1-Week Range:
$74.62
$78.06
52-Week Range:
$74.62
$100.18
Colgate Palmolive Co Stock (CL) Company Profile
Name
Colgate Palmolive Co
Sector
Industry
Phone
(212) 310-2000
Address
300 PARK AVE, NEW YORK, NY
Compare CL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
77.05 | 61.84B | 20.00B | 3.05B | 3.37B | 3.5578 |
|
PG
Procter Gamble Co
|
150.37 | 349.53B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
60.19 | 149.25B | 64.99B | 6.71B | 6.53B | 2.4355 |
|
KMB
Kimberly Clark Corp
|
119.71 | 39.90B | 18.08B | 1.81B | 2.10B | 5.904 |
|
KVUE
Kenvue Inc
|
14.37 | 27.33B | 15.14B | 1.42B | 1.63B | 0.7361 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Resumed | Piper Sandler | Neutral |
| Oct-28-24 | Downgrade | Stifel | Buy → Hold |
| Sep-24-24 | Initiated | Piper Sandler | Overweight |
| Sep-16-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Jan-29-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Oct-16-23 | Upgrade | Stifel | Hold → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Buy |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-22 | Initiated | Wolfe Research | Peer Perform |
| Oct-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-01-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-08-22 | Initiated | Raymond James | Mkt Perform |
| Feb-02-22 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Jan-31-22 | Reiterated | Citigroup | Neutral |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Deutsche Bank | Buy |
| Jan-31-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-31-22 | Reiterated | Wells Fargo | Underweight |
| Dec-16-21 | Initiated | Redburn | Neutral |
| Oct-05-21 | Resumed | BofA Securities | Neutral |
| Sep-20-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-24-21 | Initiated | UBS | Buy |
| Jun-09-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-01-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jan-28-21 | Downgrade | Stifel | Buy → Hold |
| Jan-26-21 | Upgrade | Berenberg | Sell → Hold |
| Jan-20-21 | Initiated | Bernstein | Underperform |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Jul-22-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Mar-27-20 | Upgrade | SunTrust | Hold → Buy |
| Mar-23-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-03-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Feb-03-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-19-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-16-19 | Initiated | Berenberg | Sell |
| Apr-29-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-07-19 | Initiated | Credit Suisse | Underperform |
| Feb-11-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Jan-11-19 | Initiated | Evercore ISI | Outperform |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Oct-29-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Downgrade | SunTrust | Buy → Hold |
| Jul-30-18 | Downgrade | Macquarie | Outperform → Neutral |
| May-25-18 | Upgrade | Argus | Hold → Buy |
| Apr-30-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Colgate Palmolive Co Stock (CL) Latest News
Sumitomo Life Insurance Co. Has $2.20 Million Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Sees Q3 Sales Surge: Higher Pricing Counters Volume Decline - Retail News Asia
Colgate-Palmolive posts Q3 sales growth amid higher pricing - Inside FMCG
Colgate-Palmolive Stock Still Finds Bullish Retail Support After Signaling Consumer Fatigue With Sluggish Outlook - Stocktwits
Colgate's sore about cavity in India growth curve - The Economic Times
Corporate Actions This Week: Colgate, Coal India And HPCL In Focus - NDTV Profit
Combining price and volume data for Colgate Palmolive Company2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Colgate-Palmolive (NYSE:CL) Announces Quarterly Earnings Results - MarketBeat
Colgate (CL) Q3 2025 Earnings Call Transcript - The Globe and Mail
Colgate-Palmolive Co. Stock Plummets to 52-Week Low of $75.38 - Markets Mojo
Lockheed Martin Investment Management Co. Buys Shares of 26,100 Colgate-Palmolive Company $CL - MarketBeat
Is Colgate Palmolive Company stock near bottom after declineInflation Watch & AI Forecasted Stock Moves - newser.com
Colgate-Palmolive (CL): Margin Expansion Strengthens Case for Undervaluation Versus Community Narrative - Yahoo! Finance UK
Decoding Colgate-Palmolive Co (CL): A Strategic SWOT Insight - GuruFocus
Colgate-Palmolive Co. (CL) Sees Decline in Gross Profit Margin - GuruFocus
Research Alert: CFRA Keeps Hold View On Shares Of Colgate-palmolive Company - 富途牛牛
Colgate-Palmolive Co (CL) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Colgate-Palmolive Q3 2025 Earnings Call Transcript - MarketBeat
Colgate-Palmolive Boosts Promotions to Offset Price Hikes - The Wall Street Journal
Colgate-Palmolive Lowers Sales Outlook As Shoppers Trade Down - Finimize
Colgate-Palmolive posts higher Q3 sales as pricing gains offset volume decline - CryptoRank
Net Sales Grow 2% for Colgate-Palmolive in Q3 2025 - Happi | Household And Personal Products Industry
Colgate-Palmolive Cuts Annual Sales Forecast On Signs Of Sluggish Demand - ESM Magazine
Colgate Flexes Toothpaste Crown But Stock Hits 52-week low - Benzinga
Colgate-Palmolive Q2 2025 slides reveal innovation push and productivity program - Investing.com Australia
Colgate-Palmolive Faces Sluggish Urban Demand in India - scanx.trade
Colgate-Palmolive trims FY25 sales growth outlook to reflect 'uncertainty in global markets' (CL:NYSE) - Seeking Alpha
Colgate-Palmolive cuts annual sales forecast on signs of sluggish demand By Reuters - Investing.com
Colgate-Palmolive Co (CL) Q3 2025 Earnings: EPS of $0.91 Beats Estimate, Revenue Hits $5,131 Million - GuruFocus
Colgate-Palmolive lowers full-year sales outlook, Q3 earnings top estimates - Investing.com Nigeria
Colgate-Palmolive Reaffirms FY25 EPS, Adj. EPS And Organic Sales Growth OutlookUpdate - Nasdaq
Colgate-Palmolive (NYSE:CL) Reports Q3 In Line With Expectations - Yahoo! Finance UK
Colgate-Palmolive Beats Estimates, Maintains Full-Year Guidance - Bloomberg.com
Colgate-Palmolive: Q3 Earnings Snapshot - San Antonio Express-News
Colgate-Palmolive earnings beat by $0.02, revenue was in line with estimates - Investing.com Nigeria
Colgate-Palmolive's Q3 net sales up 2% to $5.1B - breakingthenews.net
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
Large Dividends: Shree Cement, Colgate Palmolive, Oracle Financial — Last Day To Buy Shares To Qualify - NDTV Profit
Colgate Palmolive (CL) Set to Announce Earnings - GuruFocus
Colgate-Palmolive (NYSE:CL) Sets New 1-Year LowHere's What Happened - MarketBeat
Earnings call transcript: Colgate-Palmolive’s Q2 2025 sales grow amid challenges - Investing.com
Colgate-Palmolive Shares Approach Critical Earnings Test Amid Steep Decline - AD HOC NEWS
Will Colgate Palmolive Company stock outperform Nasdaq indexQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com
December 2026 Options Now Available For Colgate-Palmolive (CL) - Nasdaq
Ayurvedic Toothpaste Market Share, Sales Volume, and Price - openPR.com
Mizuho Markets Americas LLC Has $256,000 Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company $CL Shares Sold by Transcend Capital Advisors LLC - MarketBeat
Will Colgate Palmolive Company stock sustain high P E ratiosPrice Action & Low Drawdown Momentum Ideas - newser.com
Colgate-Palmolive Company $CL Holdings Lifted by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
7,021 Shares in Colgate-Palmolive Company $CL Acquired by Clark Asset Management LLC - MarketBeat
Convergence Investment Partners LLC Invests $1.18 Million in Colgate-Palmolive Company $CL - MarketBeat
Colgate Palmolive Co Stock (CL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):